Freed Investment Group - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Freed Investment Group ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$107,000
+311.5%
52,900
+262.3%
0.08%
+256.5%
Q1 2021$26,000
-10.3%
14,600
-48.8%
0.02%
-14.8%
Q4 2020$29,00028,5000.03%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Inspire Advisors, LLC 135,508$472,0000.15%
Wealth Advisory Solutions, LLC 156,850$546,0000.13%
Horst & Graben Wealth Management LLC 75,722$264,0000.07%
Miller Investment Management, LP 50,000$174,0000.03%
GSA CAPITAL PARTNERS LLP 44,655$155,0000.02%
Triton Wealth Management, PLLC 13,100$24,0000.01%
Renaissance Technologies 1,898,351$6,606,0000.01%
B. Riley Wealth Management, Inc. 19,000$66,0000.01%
Virtu Financial LLC 19,713$69,0000.01%
WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC 47,265$164,0000.01%
View complete list of CITIUS PHARMACEUTICALS INC shareholders